Dr. Soergel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 Health Plaza Dr
East Hanover, NJ 07936
Education & Training
- Weill Cornell MedicineClass of 1996
Certifications & Licensure
- PA State Medical License 2003 - 2024
- MD State Medical License 1999 - 2013
Publications & Presentations
PubMed
- 13 citationsNew perspectives for hypertension management: progress in methodological and technological developments.Gianfranco Parati, Alexandra Goncalves, David Soergel, Rosa Maria Bruno, Enrico Gianluca Caiani
European Journal of Preventive Cardiology. 2023-01-11 - 10 citationsIs plasma renin activity associated with worse outcomes in acute heart failure? A secondary analysis from the BLAST-AHF trial.Rayan Jo Rachwan, Javed Butler, Sean P. Collins, Gad Cotter, Beth A. Davison
European Journal of Heart Failure. 2019-10-23 - 17 citationsA First-in-Human Clinical Study With TRV734, an Orally Bioavailable G-Protein–Biased Ligand at the μ-Opioid ReceptorIan E. James, Franck Skobieranda, David G. Soergel, Kimberly A. Ramos, Dennis Ruff
Clinical Pharmacology in Drug Development. 2019-07-08
Press Mentions
- Novartis Oral Fabhalta® (Iptacopan) Sustained Clinically Meaningful Results at One Year in Phase III C3 Glomerulopathy (C3G) TrialOctober 26th, 2024
- Novartis Entresto Receives Positive CHMP Opinion for Pediatric Heart FailureApril 1st, 2023
- Novartis Entresto Receives Positive CHMP Opinion for Pediatric Heart FailureMarch 31st, 2023
- Join now to see all
Grant Support
- Genetic Model Of Myocardial Stunning In Immature HeartNational Heart, Lung, And Blood Institute2000–2001
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: